Pharma manufacturers must securely destroy expired or off-spec drugs to meet DEA standards, avoid compliance risks, and ...

Aficamten is a small-molecule cardiac myosin inhibitor that was compared for the first time in the trial to the standard-of-care beta blocker.

EMA and WHO have collaborated for a decade, with WHO utilizing EMA’s scientific expertise to fulfill its mandate to improve access to safe and effective medicines.

Pharmaceutical Technology serves as the connection to bio manufacturing and development, featuring regulatory updates and ...

Cereno reports that its lead program, CS1, demonstrated encouraging efficacy while meeting its primary endpoint of safety and ...

Survey responses indicate that bio/pharma faces tariff-driven rising costs and supply strain, with firms aiming to boost ...

At a critical turning point in the adoption of digital tools across the bio/pharma industry, we want to hear to industry ...

To find out how FDA’s new draft guidance, Oncology Therapeutic Radiopharmaceuticals: Dosage Optimization During Clinical ...

The laboratory services provider is responding to growing demand for packaging and microbiological testing by expanding its ...

Continued process verification ensures pharmaceutical manufacturing stays in control through data analysis, trend detection, ...

The company will be adding a 160,000-square-foot dedicated manufacturing facility at the FUJIFILM site in Holly Springs, NC.

This comprehensive overview of contemporary formulation strategies covers the drug product lifecycle from end to end, illustrating best practices for various formulation types seen through a CRDMO’s ...